Clinical Trials Browser

Phase 2 × Anemia, Refractory, with Excess of Blasts × enasidenib × Clear all

Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic